Gendiag.exe, S.L.
Records under this name other than patents Gendiag.exe, S.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Gendiag.exe, S.L.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,023,914 | Thromboembolic disease markers Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,557,170 | Thromboembolic disease markers Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,518,297 | Thromboembolic disease markers Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,814,673 | Cardiovascular disease Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,957,565 | Method for detecting polymorphisms Formerly held Lapsed on the fee record Ended May 1, 2026 · USPTO record | Lapsed on the fee record | Ended May 1, 2026 | USPTO record |